New and updated respiratory syncytial virus (RSV) resources
Home / News & Opportunities / Latest news / Current post
August 13, 2025
The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.
A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).
- Arexvy® must not be administered to pregnant women.
- Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
- Abrysvo® and Arexvy® must not be administered to infants or children.
- The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.
Updated resources include:
- RSV vaccine and monoclonal antibody poster – to facilitate appropriate choice of product
- RSV provider advice fact sheet
- RSV consumer advice fact sheet
- RSV frequently asked questions fact sheet.
For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing
Latest news
Ahead of the changes to the Aged Care Act commencing on 1 November, the Department of Health, Disability and Aged Care have released new resources for General Practitioners , Nurse Practitioners and Allied Health Providers to inform how they can support older people to access the new Support at Home (SaH) program.
Relationship Matters is offering a free Anger Management for Women program for women who want to feel more in control of their emotions, improve communication and respond to challenging situations in healthy ways.
2018-19 was a stand-out year for South Eastern Melbourne Primary Health network (SEMPHN), with practical ideas delivering important ways to help our community across south east Melbourne live healthier lives.
